• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以依奇珠单抗治疗 Hallopeau 连续性肢端皮炎。

Treatment of acrodermatitis continua of hallopeau with ixekizumab.

机构信息

Skin Care Physicians of Georgia, Macon, GA, USA.

Mercer University School of Medicine, Macon, GA, USA.

出版信息

J Dermatolog Treat. 2021 Feb;32(1):117-119. doi: 10.1080/09546634.2019.1628170. Epub 2019 Jul 5.

DOI:10.1080/09546634.2019.1628170
PMID:31184530
Abstract

Acrodermatitis continua of hallopeau (ACH) is a rare chronic inflammatory variant of pustular psoriasis often restricted to the distal portions the digits in the hands and feet. ACH is of a chronic relapsing nature and is invariably recalcitrant to many available topical and systemic anti-psoriatic therapies. On account of its low prevalence and high resistance to treatments, no clinical guideline of ACH exists. We present a patient with ACH resistant to multiple therapies, including the biologic adalimumab, who was successfully treated with an IL-17 inhibitor (ixekizumab). We believe our unique treatment with an excellent outcome may assist other dermatologists if faced with this condition.

摘要

掌跖脓疱性银屑病(Acrodermatitis continua of hallopeau,ACH)是一种罕见的慢性炎症性脓疱型银屑病变异型,通常局限于手部和脚部的远端指(趾)。ACH 具有慢性复发性,并且对许多可用的局部和全身抗银屑病治疗均具有抗性。由于其患病率低且对治疗的抵抗力高,ACH 目前尚无临床指南。我们报告了一例 ACH 患者,该患者对多种治疗方法(包括生物制剂阿达木单抗)均有耐药性,后成功接受了 IL-17 抑制剂(依奇珠单抗)治疗。我们相信,如果其他皮肤科医生遇到这种情况,我们独特的治疗方法和极佳的疗效可能会有所帮助。

相似文献

1
Treatment of acrodermatitis continua of hallopeau with ixekizumab.以依奇珠单抗治疗 Hallopeau 连续性肢端皮炎。
J Dermatolog Treat. 2021 Feb;32(1):117-119. doi: 10.1080/09546634.2019.1628170. Epub 2019 Jul 5.
2
Acrodermatitis continua of Hallopeau successfully treated with secukinumab.司库奇尤单抗成功治疗Hallopeau连续性肢端皮炎。
J Dermatolog Treat. 2018;29(sup1):3-5. doi: 10.1080/09546634.2018.1527993.
3
The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.生物疗法在 Hallopeau 连续性肢端皮炎治疗中的应用:综述。
J Cutan Med Surg. 2019 Jul/Aug;23(4):428-435. doi: 10.1177/1203475419836435. Epub 2019 Apr 2.
4
Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.生物制剂治疗 Hallopeau 连续性肢端皮炎:司库奇尤单抗治疗有效并文献复习
Dermatol Ther. 2019 May;32(3):e12899. doi: 10.1111/dth.12899. Epub 2019 Apr 29.
5
Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents.优特克单抗用于治疗对抗肿瘤坏死因子药物难治的Hallopeau连续性肢端皮炎。
Dermatol Ther. 2017 Mar;30(2). doi: 10.1111/dth.12460. Epub 2017 Jan 30.
6
Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.Hallopeau 连续性肢端皮炎(ACH):阿达木单抗成功治疗两例。
J Dermatolog Treat. 2014 Dec;25(6):489-94. doi: 10.3109/09546634.2013.848259. Epub 2013 Nov 12.
7
Treatment of Recalcitrant Acrodermatitis Continua of Hallopeau With Brodalumab.用布罗达单抗治疗哈洛佩奥顽固性连续性肢端皮炎
J Drugs Dermatol. 2019 Oct 1;18(10):1047.
8
Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.用比美吉珠单抗成功治疗的哈洛佩奥连续性肢端皮炎:一例报告
SAGE Open Med Case Rep. 2023 Mar 21;11:2050313X231160937. doi: 10.1177/2050313X231160937. eCollection 2023.
9
Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.司库奇尤单抗成功治疗合并泛发性脓疱型银屑病的Hallopeau连续性肢端皮炎:一例报告
Front Immunol. 2024 Feb 23;15:1338285. doi: 10.3389/fimmu.2024.1338285. eCollection 2024.
10
Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report.用阿达木单抗成功治疗的Hallopeau连续性肢端皮炎:一例报告
SAGE Open Med Case Rep. 2019 Feb 15;7:2050313X19829620. doi: 10.1177/2050313X19829620. eCollection 2019.

引用本文的文献

1
Acrodermatitis continua of Hallopeau: a review and update on biological and small molecule targeted immunomodulatory therapies.哈洛佩奥连续性肢端皮炎:生物和小分子靶向免疫调节疗法的综述与更新
Front Immunol. 2025 Aug 15;16:1525821. doi: 10.3389/fimmu.2025.1525821. eCollection 2025.
2
Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis.司库奇尤单抗治疗掌跖脓疱病和反向性银屑病
Indian J Dermatol. 2023 Mar-Apr;68(2):234. doi: 10.4103/ijd.ijd_884_22.
3
Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab.
用于治疗Hallopeau连续性肢端皮炎的生物制剂:两例使用司库奇尤单抗和优特克单抗成功治疗的病例报告
Dermatol Pract Concept. 2023 Apr 1;13(2). doi: 10.5826/dpc.1302a103.
4
Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.用比美吉珠单抗成功治疗的哈洛佩奥连续性肢端皮炎:一例报告
SAGE Open Med Case Rep. 2023 Mar 21;11:2050313X231160937. doi: 10.1177/2050313X231160937. eCollection 2023.
5
Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.用司库奇尤单抗成功治疗的哈洛佩奥连续性肢端皮炎:一例报告
Dermatol Ther. 2022 May;35(5):e15383. doi: 10.1111/dth.15383. Epub 2022 Feb 22.
6
Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy.孕期使用靶向治疗对匐行性皮炎进行治疗及分子特征分析
JAAD Case Rep. 2021 Sep 8;16:164-167. doi: 10.1016/j.jdcr.2021.09.002. eCollection 2021 Oct.